Clinical Impact of Atrial Fibrillation in Patients with Pulmonary Hypertension

• Dennis Rottlaender ,

  Contributed equally to this work with: Dennis Rottlaender, Lukas J. Motloch

  * E-mail: dennis.rottlaender@uk-koeln.de

  Affiliation Department of Internal Medicine II, Paracelsus Medical University, Salzburg, Austria

  ⨯
• Lukas J. Motloch ,

  Contributed equally to this work with: Dennis Rottlaender, Lukas J. Motloch

  Affiliation Department of Internal Medicine II, Paracelsus Medical University, Salzburg, Austria

  ⨯
• Daniela Schmidt,

  Affiliation Department of Internal Medicine III, University of Cologne, Cologne, Germany

  ⨯
• Sara Reda,

  Affiliation Department of Internal Medicine II, Paracelsus Medical University, Salzburg, Austria

  ⨯
• Robert Larbig,

  Affiliation Department of Internal Medicine II, Paracelsus Medical University, Salzburg, Austria

  ⨯
• Martin Wolny,

  Affiliation Center of Molecular Medicine Cologne, University of Cologne, Cologne, Germany

  ⨯
• Daniel Dumitrescu,

  Affiliation Department of Internal Medicine III, University of Cologne, Cologne, Germany

  ⨯
• Stephan Rosenkranz,

  Affiliations Department of Internal Medicine III, University of Cologne, Cologne, Germany, Center of Molecular Medicine Cologne, University of Cologne, Cologne, Germany

  ⨯
• Erland Erdmann,

  Affiliation Department of Internal Medicine III, University of Cologne, Cologne, Germany

  ⨯
• Uta C. Hoppe

  Affiliations Department of Internal Medicine II, Paracelsus Medical University, Salzburg, Austria, Department of Internal Medicine III, University of Cologne, Cologne, Germany, Center of Molecular Medicine Cologne, University of Cologne, Cologne, Germany

  ⨯